Value Sense
A
Agilent Technologies, Inc. (A)
Last Price$126.3(1.2%)
Market Cap$36.5B
LTM Net Debt to Free Cash Flow
1.3x
5Y avg
1.3x
Medical - Diagnostics & Research industry median
0.1x
Stock quality & Intrinsic value
7/10
(0.2%) overvalued
A
is (17.9%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Agilent Technologies, Inc. Net Debt to Free Cash Flow

Annual
Quarterly
LTM
Industry median
Company stand-alone
A
Healthcare
Crunching data... Almost there!
Oct'05Oct'06Oct'07Oct'08Oct'09Oct'10Oct'11Oct'12Oct'13Oct'14Oct'15Oct'16Oct'17Oct'18Oct'19Oct'20Oct'21Oct'22Oct'23Oct'24
Net Debt to Free Cash Flow
(3.0x)
(1.7x)
0.3x
1.2x
1.5x
1.8x
(1.3x)
0.0x
0.0x
(1.1x)
(0.9x)
(0.6x)
(0.9x)
(0.5x)
0.5x
1.2x
0.9x
1.7x
0.9x
1.5x
A
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for A and see if it's the right time to invest.
Dive in

Agilent Technologies, Inc. (A) Net Debt to Free Cash Flow comparison analysis

General

LTM Net Debt to Free Cash Flow

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Agilent Technologies, Inc. logo
Agilent Technologies, Inc.A
1.3x
(4.7%)
5.0%
19.8%
Median Peer Set
2.1x
(0.3%)
(7.2%)
11.6%
Natera, Inc. logo
Natera, Inc.NTRA
13.5x
32.0%
(32.1%)
(40.2%)
Quest Diagnostics Incorporated logo
Quest Diagnostics IncorporatedDGX
7.0x
(6.4%)
(6.5%)
9.2%
Thermo Fisher Scientific Inc. logo
Thermo Fisher Scientific Inc.TMO
3.5x
(4.6%)
(12.4%)
14.0%
Danaher Corporation logo
Danaher CorporationDHR
2.6x
(0.1%)
(17.9%)
16.3%
Mettler-Toledo International Inc. logo
Mettler-Toledo International Inc.MTD
2.3x
2.2%
12.7%
22.3%
Illumina, Inc. logo
Illumina, Inc.ILMN
1.9x
(2.9%)
4.6%
(28.0%)
Laboratory Corporation of America Holdings logo
Laboratory Corporation of America HoldingsLH
0.4x
(18.3%)
(65.8%)
3.4%
IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc.IDXX
(0.2x)
8.7%
25.2%
23.1%
IQVIA Holdings Inc. logo
IQVIA Holdings Inc.IQV
(0.2x)
2.8%
2.4%
8.9%
Waters Corporation logo
Waters CorporationWAT
(0.5x)
(0.5%)
(7.9%)
21.7%

A key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Oct'05Oct'06Oct'07Oct'08Oct'09Oct'10Oct'11Oct'12Oct'13Oct'14Oct'15Oct'16Oct'17Oct'18Oct'19Oct'20Oct'21Oct'22Oct'23Oct'24
Revenue
% growth
5,139.0
(28.4%)
4,973.0
(3.2%)
5,420.0
9.0%
5,774.0
6.5%
4,481.0
(22.4%)
5,444.0
21.5%
6,615.0
21.5%
6,858.0
3.7%
6,782.0
(1.1%)
6,981.0
2.9%
4,038.0
(42.2%)
4,202.0
4.1%
4,472.0
6.4%
4,914.0
9.9%
5,163.0
5.1%
5,339.0
3.4%
6,319.0
18.4%
6,848.0
8.4%
6,833.0
(0.2%)
6,510.0
(4.7%)
Cost of Goods Sold (COGS)2,617.02,315.02,451.02,578.02,189.02,514.03,086.03,254.03,247.03,388.01,997.02,005.02,063.02,227.02,358.02,502.02,912.03,126.03,368.02,975.0
Gross Profit
% margin
2,522.0
49.1%
2,658.0
53.4%
2,969.0
54.8%
3,196.0
55.4%
2,292.0
51.1%
2,930.0
53.8%
3,529.0
53.3%
3,604.0
52.6%
3,535.0
52.1%
3,593.0
51.5%
2,041.0
50.5%
2,197.0
52.3%
2,409.0
53.9%
2,687.0
54.7%
2,805.0
54.3%
2,837.0
53.1%
3,407.0
53.9%
3,722.0
54.4%
3,465.0
50.7%
3,535.0
54.3%
Operating Expenses2,341.02,194.02,385.02,401.02,245.02,364.02,458.02,485.02,584.02,762.01,519.01,582.01,568.01,759.01,864.01,991.02,060.02,104.02,115.02,047.0
Research & Development Expenses (R&D)738.0655.0685.0704.0642.0612.0649.0668.0704.0719.0330.0329.0339.0385.0404.0495.0441.0467.0481.0479.0
Selling, General & Administrative Expenses (SG&A)1,603.01,660.01,700.01,697.01,603.01,752.01,809.01,817.01,880.02,043.01,189.01,253.01,229.01,374.01,460.01,496.01,619.01,637.01,634.01,568.0
Operating Income
% margin
181.0
3.5%
464.0
9.3%
584.0
10.8%
795.0
13.8%
47.0
1.0%
566.0
10.4%
1,071.0
16.2%
1,119.0
16.3%
951.0
14.0%
831.0
11.9%
522.0
12.9%
615.0
14.6%
841.0
18.8%
928.0
18.9%
941.0
18.2%
846.0
15.8%
1,347.0
21.3%
1,618.0
23.6%
1,350.0
19.8%
1,488.0
22.9%
Interest Income0.00.0172.0113.029.020.014.09.07.09.07.011.022.038.036.08.02.09.051.080.0
Interest Expense0.00.091.0123.088.096.086.0101.0107.0113.066.072.079.075.074.078.081.084.095.096.0
Pre-tax Income254.0627.0670.0815.07.0692.01,032.01,043.0859.0646.0480.0544.0803.0946.0919.0842.01,360.01,504.01,339.01,521.0
Income Tax
% effective tax rate
155.0
61.0%
91.0
14.5%
32.0
4.8%
122.0
15.0%
38.0
542.9%
68.0
9.8%
20.0
1.9%
(110.0)
(10.5%)
135.0
15.7%
149.0
23.1%
45.0
9.4%
84.0
15.4%
119.0
14.8%
630.0
66.6%
(152.0)
(16.5%)
123.0
14.6%
150.0
11.0%
250.0
16.6%
99.0
7.4%
232.0
15.3%
Net Income
% margin
327.0
6.4%
3,307.0
66.5%
638.0
11.8%
693.0
12.0%
(31.0)
(0.7%)
624.0
11.5%
1,012.0
15.3%
1,153.0
16.8%
724.0
10.7%
497.0
7.1%
398.0
9.9%
460.0
10.9%
684.0
15.3%
316.0
6.4%
1,071.0
20.7%
719.0
13.5%
1,210.0
19.1%
1,254.0
18.3%
1,240.0
18.1%
1,289.0
19.8%
EPS0.667.671.621.91(0.09)1.802.923.312.121.491.201.412.120.983.412.333.984.194.224.43
Diluted EPS0.657.501.571.87(0.09)1.772.853.272.101.471.191.402.100.973.372.303.944.184.194.43
EBITDA
% margin
396.0
7.7%
634.0
12.7%
775.0
14.3%
1,139.0
19.7%
257.0
5.7%
788.0
14.5%
1,395.0
21.1%
1,445.0
21.1%
758.0
11.2%
648.0
9.3%
778.0
19.3%
863.0
20.5%
1,096.0
24.5%
1,181.0
24.0%
1,281.0
24.8%
1,353.0
25.3%
1,725.0
27.3%
1,994.0
29.1%
1,703.0
24.9%
1,488.0
22.9%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Agilent Technologies, Inc.'s Net Debt to Free Cash Flow?

As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is 1.3x, based on the financial report for Jan 31, 2025 (Q1’2025). The average annual Net Debt to Free Cash Flow for Agilent Technologies, Inc. have been 1.2x over the past three years, and 1.4x over the past five years.

2) Is Agilent Technologies, Inc.'s Net Debt to Free Cash Flow Good?

As of today, Agilent Technologies, Inc.'s Net Debt to Free Cash Flow is 1.3x, which is higher than industry median of 0.1x. It indicates that Agilent Technologies, Inc.'s Net Debt to Free Cash Flow is Bad.

3) How does Agilent Technologies, Inc.'s Net Debt to Free Cash Flow compare to its peers?

As of today, Agilent Technologies, Inc.'s Net Debt to Free Cash Flow is 1.3x, which is lower than peer median of 2.1x. The list of peers includes NTRA, DGX, TMO, DHR, MTD, ILMN, LH, IDXX, IQV, WAT.